Alliance A222001: A randomized, double-blind, placebo controlled phase II study of oxybutynin versus placebo for the treatment of hot flashes in men receiving androgen deprivation therapy.

Authors :: Stish, Brad J.
Mazza, Gina L.
Nauseef, Jones T.
Humeniuk, Michael Sandon
Smith, Thomas J.
Tofthagen, Cindy
Diaz Pardo, Dayssy Alexandra
Chay, Christopher H.
Huang, Andrew Jonathan
Naha, Kushal
Tagawa, Scott T.
Chow, Selina Lai-ming
Adams-Campbell, Lucile L.
Novotny, Paul J.
Loprinzi, Charles L.
Source :: Journal of Clinical Oncology; 2024 Supplement 17, Vol. 42, pLBA12004-LBA12004, 83p
Publication Year :: 2024

Full Text Access

Tools